108 related articles for article (PubMed ID: 20857961)
1. Influence of cyclosporine A on molecular interactions in lyotropic reverse hexagonal liquid crystals.
Ben Ishai P; Libster D; Aserin A; Garti N; Feldman Y
J Phys Chem B; 2010 Oct; 114(40):12785-91. PubMed ID: 20857961
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A.
Libster D; Ishai PB; Aserin A; Shoham G; Garti N
Int J Pharm; 2009 Feb; 367(1-2):115-26. PubMed ID: 18977286
[TBL] [Abstract][Full Text] [Related]
3. Modulation of physical properties of reverse hexagonal mesophases: a dielectric spectroscopy study.
Mishraki T; Ben Ishai P; Babukh D; Aserin A; Feldman Y; Garti N
J Colloid Interface Sci; 2013 Apr; 396():178-86. PubMed ID: 23415506
[TBL] [Abstract][Full Text] [Related]
4. The dielectric study of insulin-loaded reverse hexagonal (H(II)) liquid crystals.
Mishraki-Berkowitz T; Ben Ishai P; Aserin A; Feldman Y; Garti N
Phys Chem Chem Phys; 2015 Apr; 17(14):9499-508. PubMed ID: 25767829
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions in lyotropic reverse hexagonal liquid crystals: a dielectric spectroscopy study.
Ishai PB; Libster D; Aserin A; Garti N; Feldman Y
J Phys Chem B; 2009 Sep; 113(38):12639-47. PubMed ID: 19722513
[TBL] [Abstract][Full Text] [Related]
6. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
7. Transitions induced by solubilized fat into reverse hexagonal mesophases.
Amar-Yuli I; Garti N
Colloids Surf B Biointerfaces; 2005 Jun; 43(2):72-82. PubMed ID: 15921902
[TBL] [Abstract][Full Text] [Related]
8. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
[TBL] [Abstract][Full Text] [Related]
9. Low viscosity reversed hexagonal mesophases induced by hydrophilic additives.
Amar-Yuli I; Wachtel E; Shalev DE; Aserin A; Garti N
J Phys Chem B; 2008 Apr; 112(13):3971-82. PubMed ID: 18324809
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C.
Bitan-Cherbakovsky L; Yuli-Amar I; Aserin A; Garti N
Langmuir; 2010 Mar; 26(5):3648-53. PubMed ID: 20175578
[TBL] [Abstract][Full Text] [Related]
11. Solubilization of nutraceuticals into reverse hexagonal mesophases.
Amar-Yuli I; Aserin A; Garti N
J Phys Chem B; 2008 Aug; 112(33):10171-80. PubMed ID: 18665631
[TBL] [Abstract][Full Text] [Related]
12. Solubilization of gabapentin into HII mesophases.
Achrai B; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Feb; 115(5):825-35. PubMed ID: 21182317
[TBL] [Abstract][Full Text] [Related]
13. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
[TBL] [Abstract][Full Text] [Related]
14. Lysozyme entrapped within reverse hexagonal mesophases: physical properties and structural behavior.
Mishraki T; Libster D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):47-56. PubMed ID: 19748240
[TBL] [Abstract][Full Text] [Related]
15. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions.
Bitan-Cherbakovsky L; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Oct; 115(42):11984-92. PubMed ID: 21902258
[TBL] [Abstract][Full Text] [Related]
16. Oil and drug control the release rate from lyotropic liquid crystals.
Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
[TBL] [Abstract][Full Text] [Related]
17. Unit cell structure of water-filled monoolein in inverted hexagonal mesophase in the presence of incorporated tricaprylin and entrapped lysozyme.
Kolev V; Ivanova A; Madjarova G; Aserin A; Garti N
Eur Biophys J; 2016 Mar; 45(2):99-112. PubMed ID: 26424533
[TBL] [Abstract][Full Text] [Related]
18. Lipolysis and structure controlled drug release from reversed hexagonal mesophase.
Garti N; Hoshen G; Aserin A
Colloids Surf B Biointerfaces; 2012 Jun; 94():36-43. PubMed ID: 22341515
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
[TBL] [Abstract][Full Text] [Related]
20. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac.
Cohen-Avrahami M; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):131-8. PubMed ID: 20189781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]